- Home
- NWG vs ZTS Comparison
NWG vs ZTS Comparison
Compare NWG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWG
- ZTS
- Stock Information
- Founded
- NWG 1727
- ZTS 1952
- Country
- NWG United Kingdom
- ZTS United States
- Employees
- NWG N/A
- ZTS N/A
- Industry
- NWG Commercial Banks
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- NWG Finance
- ZTS Health Care
- Exchange
- NWG Nasdaq
- ZTS Nasdaq
- Market Cap
- NWG 59.2B
- ZTS 66.2B
- IPO Year
- NWG N/A
- ZTS 2013
- Fundamental
- Price
- NWG $14.43
- ZTS $146.93
- Analyst Decision
- NWG Strong Buy
- ZTS Buy
- Analyst Count
- NWG 1
- ZTS 8
- Target Price
- NWG N/A
- ZTS $200.25
- AVG Volume (30 Days)
- NWG 3.6M
- ZTS 2.4M
- Earning Date
- NWG 10-24-2025
- ZTS 11-03-2025
- Dividend Yield
- NWG 4.40%
- ZTS 1.36%
- EPS Growth
- NWG 25.48
- ZTS 14.10
- EPS
- NWG 0.82
- ZTS 5.82
- Revenue
- NWG $20,360,323,334.00
- ZTS $9,385,000,000.00
- Revenue This Year
- NWG $15.92
- ZTS $3.90
- Revenue Next Year
- NWG $6.44
- ZTS $5.92
- P/E Ratio
- NWG $8.58
- ZTS $25.21
- Revenue Growth
- NWG 8.06
- ZTS 5.27
- 52 Week Low
- NWG $8.70
- ZTS $139.70
- 52 Week High
- NWG $15.52
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- NWG 50.77
- ZTS 37.85
- Support Level
- NWG $13.74
- ZTS $145.89
- Resistance Level
- NWG $14.74
- ZTS $152.00
- Average True Range (ATR)
- NWG 0.18
- ZTS 2.94
- MACD
- NWG -0.00
- ZTS -0.76
- Stochastic Oscillator
- NWG 72.84
- ZTS 9.76
About NWG NatWest Group plc (each representing two (2))
NatWest Group derives around 90% of its total income from the United Kingdom. The bank operates a retail, commercial, and private bank in the UK, offering clients lending and payment services as well as asset management services.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.